atezolizumab,cabozantinib
roche,exelixis
['cosmic-021', 'urothelial', 'atezo', 'blcsm', 'cabozantinib']
according to new cosmic-021 data, #atezolizumab combined with #cabozantinib may be active in patients with #urothelialcarcinoma.
#uc #blcsm #asco22 
Oncology news and insights from leading researchers and cancer centers.